These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 29935669)

  • 1. Genome-Wide Association Studies Identify Disease Mechanisms in Age-Related Macular Degeneration.
    Wright AF; Barlow PN
    Ophthalmology; 2018 Jul; 125(7):962-964. PubMed ID: 29935669
    [No Abstract]   [Full Text] [Related]  

  • 2. Genotype distribution-based inference of collective effects in genome-wide association studies: insights to age-related macular degeneration disease mechanism.
    Woo HJ; Yu C; Kumar K; Gold B; Reifman J
    BMC Genomics; 2016 Aug; 17(1):695. PubMed ID: 27576376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic aspects of age-related macular degeneration.
    Horie-Inoue K; Inoue S
    Biochem Biophys Res Commun; 2014 Sep; 452(2):263-75. PubMed ID: 25111812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiallelic copy number variation in the complement component 4A (C4A) gene is associated with late-stage age-related macular degeneration (AMD).
    Grassmann F; Cantsilieris S; Schulz-Kuhnt AS; White SJ; Richardson AJ; Hewitt AW; Vote BJ; Schmied D; Guymer RH; Weber BH; Baird PN
    J Neuroinflammation; 2016 Apr; 13(1):81. PubMed ID: 27090374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential DNA methylation identified in the blood and retina of AMD patients.
    Oliver VF; Jaffe AE; Song J; Wang G; Zhang P; Branham KE; Swaroop A; Eberhart CG; Zack DJ; Qian J; Merbs SL
    Epigenetics; 2015; 10(8):698-707. PubMed ID: 26067391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related macular degeneration: Complement in action.
    van Lookeren Campagne M; Strauss EC; Yaspan BL
    Immunobiology; 2016 Jun; 221(6):733-9. PubMed ID: 26742632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomewide association studies and assessment of risk of disease.
    Rienhoff HY
    N Engl J Med; 2010 Nov; 363(21):2077; author reply 2077. PubMed ID: 21083405
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic pleiotropy between age-related macular degeneration and 16 complex diseases and traits.
    Grassmann F; Kiel C; Zimmermann ME; Gorski M; Grassmann V; Stark K; ; Heid IM; Weber BH
    Genome Med; 2017 Mar; 9(1):29. PubMed ID: 28347358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide analysis of single nucleotide polymorphisms in patients with atrophic age-related macular degeneration in oldest old Han Chinese.
    Zhou TQ; Guan HJ; Hu JY
    Genet Mol Res; 2015 Dec; 14(4):17432-8. PubMed ID: 26782385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly penetrant alleles in age-related macular degeneration.
    den Hollander AI; de Jong EK
    Cold Spring Harb Perspect Med; 2014 Nov; 5(3):a017202. PubMed ID: 25377141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMD and the alternative complement pathway: genetics and functional implications.
    Tan PL; Bowes Rickman C; Katsanis N
    Hum Genomics; 2016 Jun; 10(1):23. PubMed ID: 27329102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide association study success in ophthalmology.
    Mackey DA; Hewitt AW
    Curr Opin Ophthalmol; 2014 Sep; 25(5):386-93. PubMed ID: 25014751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographic distribution of rare variants associated with age-related macular degeneration.
    Geerlings MJ; Kersten E; Groenewoud JMM; Fritsche LG; Hoyng CB; de Jong EK; den Hollander AI
    Mol Vis; 2018; 24():75-82. PubMed ID: 29410599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants in microRNAs and their binding sites within gene 3'UTRs associate with susceptibility to age-related macular degeneration.
    Ghanbari M; Erkeland SJ; Xu L; Colijn JM; Franco OH; Dehghan A; Klaver CCW; Meester-Smoor MA
    Hum Mutat; 2017 Jul; 38(7):827-838. PubMed ID: 28397307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration.
    Saksens NT; Lechanteur YT; Verbakel SK; Groenewoud JM; Daha MR; Schick T; Fauser S; Boon CJ; Hoyng CB; den Hollander AI
    PLoS One; 2016; 11(6):e0144367. PubMed ID: 27258093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study.
    Ennis S; Jomary C; Mullins R; Cree A; Chen X; Macleod A; Jones S; Collins A; Stone E; Lotery A
    Lancet; 2008 Nov; 372(9652):1828-34. PubMed ID: 18842294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Almost total protection from age-related macular degeneration by haplotypes of the Regulators of Complement Activation.
    Williamson JF; McLure CA; Guymer RH; Baird PN; Millman J; Cantsilieris S; Dawkins RL
    Genomics; 2011 Dec; 98(6):412-21. PubMed ID: 21855625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population.
    Momozawa Y; Akiyama M; Kamatani Y; Arakawa S; Yasuda M; Yoshida S; Oshima Y; Mori R; Tanaka K; Mori K; Inoue S; Terasaki H; Yasuma T; Honda S; Miki A; Inoue M; Fujisawa K; Takahashi K; Yasukawa T; Yanagi Y; Kadonosono K; Sonoda KH; Ishibashi T; Takahashi A; Kubo M
    Hum Mol Genet; 2016 Nov; 25(22):5027-5034. PubMed ID: 28173125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between Y402H, E318D and R102G polymorphisms of complement proteins genes and the response to intravitreal anti-VEGF treatment in patients with neovascular age-related macular degeneration].
    Kubicka-Trząska A; Karska-Basta I; Kobylarz J; Dziedzina S; Sanak M; Romanowska-Dixon B
    Klin Oczna; 2016; 118(2):114-21. PubMed ID: 29912491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration.
    Yamashiro K; Mori K; Honda S; Kano M; Yanagi Y; Obana A; Sakurada Y; Sato T; Nagai Y; Hikichi T; Kataoka Y; Hara C; Koyama Y; Koizumi H; Yoshikawa M; Miyake M; Nakata I; Tsuchihashi T; Horie-Inoue K; Matsumiya W; Ogasawara M; Obata R; Yoneyama S; Matsumoto H; Ohnaka M; Kitamei H; Sayanagi K; Ooto S; Tamura H; Oishi A; Kabasawa S; Ueyama K; Miki A; Kondo N; Bessho H; Saito M; Takahashi H; Tan X; Azuma K; Kikushima W; Mukai R; Ohira A; Gomi F; Miyata K; Takahashi K; Kishi S; Iijima H; Sekiryu T; Iida T; Awata T; Inoue S; Yamada R; Matsuda F; Tsujikawa A; Negi A; Yoneya S; Iwata T; Yoshimura N
    Sci Rep; 2017 Aug; 7(1):9196. PubMed ID: 28835685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.